DTIL - Precision BioSciences, Inc. -  [ ]

Ticker Details
Precision BioSciences, Inc.
IPO Date: May 25, 2019
Sector: Healthcare
Industry: Biotech
Market Cap: $236.35M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.27 | 4.20%
Avg Daily Range (30 D): $0.30 | 4.13%
Avg Daily Range (90 D): $0.30 | 4.54%
Institutional Daily Volume
Avg Daily Volume: .11M
Avg Daily Volume (30 D): .46M
Avg Daily Volume (90 D): .32M
Trade Size
Avg Trade Size (Sh.): 31
Avg Trade Size (Sh.) (30 D): 79
Avg Trade Size (Sh.) (90 D): 75
Institutional Trades
Total Institutional Trades: 333
Avg Institutional Trade: $1.44M
Avg Institutional Trade (30 D): $2.87M
Avg Institutional Trade (90 D): $2.61M
Avg Institutional Trade Volume: .02M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.59M
Avg Closing Trade (30 D): $4.13M
Avg Closing Trade (90 D): $3.47M
Avg Closing Volume: 19.72K
 
News
Jul 3, 2026 @ 8:44 AM
Gene Editing Therapeutics: Transforming Biopharmac...
Source: Researchandmarkets.Com
May 26, 2026 @ 5:00 PM
Duchenne Muscular Dystrophy Clinical Trial Pipelin...
Source: Delveinsight
Jan 22, 2026 @ 9:56 AM
Genome Editing Market Forecast to Reach $23.6 Bill...
Source: Researchandmarkets.Com
Mar 5, 2025 @ 6:00 PM
CAR T-cell Therapy Clinical Trial Pipeline Experie...
Source: Delveinsight
Sep 10, 2024 @ 9:00 AM
Global Genetic Engineering Market Size To Worth US...
Source: Spherical Insights & Consulting
Financials
  TTM Q1 2026 Q4 2025
Basic EPS $-2.14 $-.75 $2.58
Diluted EPS $-2.14 $-.75 $2.58
Revenue $45.07M $10.84M $34.2M
Gross Profit
Net Income / Loss $-43.6M $-18.44M $20.13M
Operating Income / Loss $-39.11M $-9.08M $12.51M
Cost of Revenue
Net Cash Flow $26.06M $-11.31M $65.94M
PE Ratio    
Splits
Feb 14, 2024 1:30